Cargando…

SOX10 modulated SMARCA4 dysregulation alleviates DNA replication stress in cutaneous melanoma

Cutaneous melanoma (CM) is the most fatal type of skin cancer with a high potency of metastasis, yet the treatment for metastatic melanoma remains limited. In this study, we are devoted to addressing the prognostic value and underlying mechanism of DNA damage repair‐related genes in CM. We utilized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Xiangjian, Rao, Keqiang, Wei, Zhiyi, Cheng, Juntao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716224/ https://www.ncbi.nlm.nih.gov/pubmed/36317703 http://dx.doi.org/10.1111/jcmm.17607

Ejemplares similares

SOX10-MITF pathway activity in melanoma cells
por: Tudrej, Karol B, et al.
Publicado: (2016)

Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023)

Identification and functional analysis of SOX10 phosphorylation sites in melanoma
por: Cronin, Julia C., et al.
Publicado: (2018)

SMARCA4 deficiency-associated heterochromatin induces intrinsic DNA replication stress and susceptibility to ATR inhibition in lung adenocarcinoma
por: Kurashima, Kiminori, et al.
Publicado: (2020)

Antagonistic Cross-Regulation between Sox9 and Sox10 Controls an Anti-tumorigenic Program in Melanoma
por: Shakhova, Olga, et al.
Publicado: (2015)

SOX11, SOX10 and MITF Gene Interaction: A Possible Diagnostic Tool in Malignant Melanoma
por: Beleaua, Marius-Alexandru, et al.
Publicado: (2021)

SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2
por: Mehta, Gaurav A., et al.
Publicado: (2021)

Gene signature reveals decreased SOX10-dependent transcripts in malignant cells from immune checkpoint inhibitor-resistant cutaneous melanomas
por: Purwin, Timothy J., et al.
Publicado: (2023)

High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
por: Guerrero-Martínez, Jose A., et al.
Publicado: (2018)

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
por: Cantley, Jennifer, et al.
Publicado: (2022)

Diagnostic value of SOX-10 immunohistochemical staining for the detection of uveal melanoma
por: Alghamdi, Sarah A, et al.
Publicado: (2015)

The transcription factor Sox5 modulates Sox10 function during melanocyte development
por: Stolt, C. Claus, et al.
Publicado: (2008)

SOX4-SMARCA4 complex promotes glycolysis-dependent TNBC cell growth through transcriptional regulation of Hexokinase 2
por: Khanna, Pooja, et al.
Publicado: (2023)

Complex Alternative Splicing of the Smarca2 Gene Suggests the Importance of Smarca2-B Variants
por: Yang, Min, et al.
Publicado: (2011)

Functional in vivo characterization of sox10 enhancers in neural crest and melanoma development
por: Cunningham, Rebecca L., et al.
Publicado: (2021)

Regulation of SOX10 stability via ubiquitination-mediated degradation by Fbxw7α modulates melanoma cell migration
por: Lv, Xiao-Bin, et al.
Publicado: (2015)

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type
por: Jelinic, Petar, et al.
Publicado: (2016)

Coordinated epigenetic regulation of Engrailed-1 by the chromatin remodelers Smarca1 and Smarca5 mediates cerebellar morphogenesis
por: Alvarez-Saavedra, Matias, et al.
Publicado: (2013)

SOX10 Knockdown Inhibits Melanoma Cell Proliferation via Notch Signaling Pathway
por: Tang, Youqun, et al.
Publicado: (2021)

SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects
por: Rosenbaum, Sheera R., et al.
Publicado: (2021)

Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
por: Capparelli, Claudia, et al.
Publicado: (2022)

The Dysregulation of SOX Family Correlates with DNA Methylation and Immune Microenvironment Characteristics to Predict Prognosis in Hepatocellular Carcinoma
por: Qin, Sha, et al.
Publicado: (2022)

SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines
por: Ehrenhöfer-Wölfer, Katharina, et al.
Publicado: (2019)

Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review)
por: Volovat, Simona Ruxandra, et al.
Publicado: (2021)

New insights into DNA methylation signatures: SMARCA2 variants in Nicolaides-Baraitser syndrome
por: Chater-Diehl, Eric, et al.
Publicado: (2019)

MALIGNANT MELANOMA – CUTANEOUS METASTASES
por: Padmavathy, L, et al.
Publicado: (2008)

The Emerging Roles of circSMARCA5 in Cancer
por: Qin, Haoyu, et al.
Publicado: (2022)

Thoracic SMARCA4-deficient undifferentiated tumor
por: Jiang, Jiapeng, et al.
Publicado: (2023)

The SOXE transcription factors—SOX8, SOX9 and SOX10—share a bi-partite transactivation mechanism
por: Haseeb, Abdul, et al.
Publicado: (2019)

ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
por: Han, Shujun, et al.
Publicado: (2018)

CEACAM1 is a direct SOX10 target and inhibits melanoma immune infiltration and stemness
por: Abou-Hamad, John, et al.
Publicado: (2022)

Sox10 Controls Migration of B16F10 Melanoma Cells through Multiple Regulatory Target Genes
por: Seong, Ikjoo, et al.
Publicado: (2012)

TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets TGFB2 and SOX2
por: Zhou, Cixiang, et al.
Publicado: (2022)

Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis
por: Gajjala, Prathibha R., et al.
Publicado: (2021)

PARP10 promotes cellular proliferation and tumorigenesis by alleviating replication stress
por: Schleicher, Emily M, et al.
Publicado: (2018)

DNA repair goes hip-hop: SMARCA and CHD chromatin remodellers join the break dance
por: Rother, Magdalena B., et al.
Publicado: (2017)

Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay
por: Blokzijl, Andries, et al.
Publicado: (2016)

Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review
por: Duan, Huanli, et al.
Publicado: (2021)

The SMARCA4(R1157W) mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer
por: Zeng, Xiangwei, et al.
Publicado: (2023)

Cutaneous melanoma
por: Négrier, S, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_7esheh9edsrm5i6j5f3vr9m5hk